Gelatinase activity in synovial fluid and synovium obtained from healthy and osteoarthritic joints of dogs. 2003

Susan W Volk, and Amy S Kapatkin, and Mark E Haskins, and Raquel M Walton, and Marina D'Angelo
Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104-6044, USA.

OBJECTIVE To determine matrix metalloproteinase (MMP) activity in synovial fluid (SF) obtained from the joints of dogs with degenerative joint disease (DJD) secondary to various underlying conditions. METHODS 35 samples of SF obtained from 18 clinically normal (control) dogs and 34 samples of SF obtained from 17 dogs with DJD; dogs with DJD were from 2 populations (client-owned dogs and research dogs that had DJD secondary to the lysosomal storage disease mucopolysaccharidosis VII). METHODS MMP activity in samples of SF was semiquantitatively examined by use of gelatin or casein zymography. Western blot analysis was performed by use of antibodies for MMP-2 and MMP-9. In addition, in situ MMP activity was observed in sections of synovial membrane obtained from healthy and osteoarthritic joints. RESULTS Samples of SF from osteoarthritic joints had higher MMP-2 activity and dramatically increased MMP-9 activity, compared with values for healthy joints. Substrate-overlay analyses indicated minimal gelatin-degrading activity in synoviocytes obtained from control dogs, whereas greater activity was seen in osteoarthritic synoviocytes, with additional activity in the underlying tissue. CONCLUSIONS Higher MMP-2 activity and dramatic increases in MMP-9 activity were associated with the osteoarthritic state, even though MMP-2 activity was detected in healthy joints. This study expands information on MMP production in SF of osteoarthritic joints in other species and documents the similarity of MMP activity patterns regardless of the cause of DJD.

UI MeSH Term Description Entries
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004283 Dog Diseases Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used. Canine Diseases,Canine Disease,Disease, Canine,Disease, Dog,Diseases, Canine,Diseases, Dog,Dog Disease
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013582 Synovial Fluid The clear, viscous fluid secreted by the SYNOVIAL MEMBRANE. It contains mucin, albumin, fat, and mineral salts and serves to lubricate joints. Synovia,Fluid, Synovial,Fluids, Synovial,Synovial Fluids
D013583 Synovial Membrane The inner membrane of a joint capsule surrounding a freely movable joint. It is loosely attached to the external fibrous capsule and secretes SYNOVIAL FLUID. Synovium,Membrana Synovialis Capsulae Articularis,Membrane, Synovial,Membranes, Synovial,Synovial Membranes
D016538 Mucopolysaccharidosis VII Mucopolysaccharidosis characterized by excessive dermatan and heparan sulfates in the urine and Hurler-like features. It is caused by a deficiency of beta-glucuronidase. Sly Syndrome,GUSB Deficiency,Mucopolysaccharidosis 7,Mucopolysaccharidosis Type VII,Sly Disease,beta-Glucuronidase Deficiency,Deficiencies, GUSB,Deficiencies, beta-Glucuronidase,Deficiency, GUSB,Deficiency, beta-Glucuronidase,Disease, Sly,GUSB Deficiencies,Mucopolysaccharidosis Type VIIs,Mucopolysaccharidosis VIIs,Syndrome, Sly,Type VII, Mucopolysaccharidosis,Type VIIs, Mucopolysaccharidosis,VIIs, Mucopolysaccharidosis,beta Glucuronidase Deficiency,beta-Glucuronidase Deficiencies
D020778 Matrix Metalloproteinase 2 A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain. Gelatinase A,72-kDa Gelatinase,72-kDa Type IV Collagenase,MMP-2 Metalloproteinase,MMP2 Metalloproteinase,Matrix Metalloproteinase-2,72 kDa Gelatinase,72 kDa Type IV Collagenase,Gelatinase, 72-kDa,MMP 2 Metalloproteinase,Metalloproteinase 2, Matrix,Metalloproteinase, MMP-2,Metalloproteinase, MMP2
D020780 Matrix Metalloproteinase 9 An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V. Gelatinase B,92-kDa Gelatinase,92-kDa Type IV Collagenase,MMP-9 Metalloproteinase,MMP9 Metalloproteinase,Matrix Metalloproteinase-9,92 kDa Gelatinase,92 kDa Type IV Collagenase,MMP 9 Metalloproteinase,Metalloproteinase 9, Matrix,Metalloproteinase, MMP-9,Metalloproteinase, MMP9

Related Publications

Susan W Volk, and Amy S Kapatkin, and Mark E Haskins, and Raquel M Walton, and Marina D'Angelo
November 2014, European journal of medical research,
Susan W Volk, and Amy S Kapatkin, and Mark E Haskins, and Raquel M Walton, and Marina D'Angelo
May 1995, Annals of the rheumatic diseases,
Susan W Volk, and Amy S Kapatkin, and Mark E Haskins, and Raquel M Walton, and Marina D'Angelo
January 2020, Frontiers in veterinary science,
Susan W Volk, and Amy S Kapatkin, and Mark E Haskins, and Raquel M Walton, and Marina D'Angelo
November 2017, Journal of biomedical materials research. Part B, Applied biomaterials,
Susan W Volk, and Amy S Kapatkin, and Mark E Haskins, and Raquel M Walton, and Marina D'Angelo
December 2002, Clinical immunology (Orlando, Fla.),
Susan W Volk, and Amy S Kapatkin, and Mark E Haskins, and Raquel M Walton, and Marina D'Angelo
May 2019, Rheumatology (Oxford, England),
Susan W Volk, and Amy S Kapatkin, and Mark E Haskins, and Raquel M Walton, and Marina D'Angelo
September 2022, Parasites & vectors,
Susan W Volk, and Amy S Kapatkin, and Mark E Haskins, and Raquel M Walton, and Marina D'Angelo
January 2015, Veterinary record open,
Susan W Volk, and Amy S Kapatkin, and Mark E Haskins, and Raquel M Walton, and Marina D'Angelo
May 2016, International journal of rheumatic diseases,
Susan W Volk, and Amy S Kapatkin, and Mark E Haskins, and Raquel M Walton, and Marina D'Angelo
April 2016, Arthritis research & therapy,
Copied contents to your clipboard!